Sort
46,585 grants matching “heart failure”
Optimizing Medications and Lung Health in People with HIV through Pharmacist-led Proactive E-Consults (OPTIMIZE Lung-HIV)
$803,801Kristina Anne Crothers · Seattle Inst For Biomedical/Clinical Res · R01 · FY2025 · HL
Chromatin Regulation of Immune Cells in Myocardial Inflammation
$803,768Michael Alexanian · J. David Gladstone Institutes · R01 · FY2025 · HL
Molecular pathogenesis of pulmonary arterial hypertension
$803,744Akiko Hata · University Of California, San Francisco · R01 · FY2021 · HL
Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
$803,705Kyle Mitchell Hocking · Volumetrix, Llc · R44 · FY2019 · HL
Translational Center for In Vivo Mitochondrial Medicine
$803,699David J Marcinek · University Of Washington · RC2 · FY2009 · AG
Washington University AsthmaNet
$803,678Mario Castro · Washington University · U10 · FY2011 · HL
Elucidating the Role of Adipokines in Mediating and Predicting HF Associated with Obesity
$803,608Chiadi E Ndumele · Johns Hopkins University · R01 · FY2020 · HL
Pulmonary Hypertension in Left Heart Disease
$803,492Margaret M Redfield · Mayo Clinic Rochester · R01 · FY2023 · HL
The WHI Strong and Healthy SilenT Atrial fibrillation Recording study (WHISH STAR)
$803,367Marco Valentin Perez · Stanford University · R01 · FY2019 · HL
Cardiovascular Risk, Vascular and Kidney Damage in COVID-19 Survivors
$803,324Julio Alonso Chirinos Medina · University Of Pennsylvania · R01 · FY2022 · HL
Effects of Exercise on Inflammation-Induced Lung and Muscle Injury in Critical Illness (NEXIS-FLAME)
$803,292Benjamin T Suratt · University Of Vermont & St Agric College · R01 · FY2018 · HL
Cardiac Growth and Function Trajectories after Preterm Birth
$803,136Kara N Goss · Ut Southwestern Medical Center · R01 · FY2025 · HL
Cardiac Autonomic Activation In Atrial Fibrillation Triggers And Substrate
$802,991Miguel Valderrabano · Methodist Hospital Research Institute · R01 · FY2025 · HL
Cardiac Autonomic Activation In Atrial Fibrillation Triggers And Substrate
$802,991Miguel Valderrabano · Methodist Hospital Research Institute · R01 · FY2023 · HL
Cardiopulmonary structure and function in Multi-Ethnic Study of Atherosclerosis
$802,884R Graham Barr · Columbia University Health Sciences · R01 · FY2011 · HL
Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac Surgery
$802,772Amanda A Fox · Ut Southwestern Medical Center · R01 · FY2019 · HL
Targeting Ketone Metabolism as a Novel Heart Failure Therapy
$802,632Daniel Patrick Kelly · University Of Pennsylvania · R01 · FY2022 · HL
Targeting Ketone Metabolism as a Novel Heart Failure Therapy
$802,632Daniel Patrick Kelly · University Of Pennsylvania · R01 · FY2023 · HL
MRI of epicardial adipose tissue composition: development of methods and application to heart failure with preserved ejection fraction
$802,611Frederick H. Epstein · University Of Virginia · R01 · FY2025 · HL
Urocortin-2 Gene Transfer for CHF: a Paracrine Approach Using Intravenous AAV8
$802,500H. Kirk Hammond · Renova Therapeutics, Inc. · R42 · FY2017 · HL
Urocortin-2 Gene Transfer for CHF: a Paracrine Approach Using Intravenous AAV8
$802,500H. Kirk Hammond · Renova Therapeutics, Inc. · R42 · FY2016 · HL
Cardiac Fibroblasts in Postnatal Development and Adult Injury Response
$802,498Katherine E Yutzey · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · HL
From Evidence to Policy: Tailoring GLP-1RA Coverage for Optimal Health Outcomes
$802,363Hui Shao · Emory University · R01 · FY2025 · DK
Targeting Ketone Metabolism as a Novel Heart Failure Therapy
$802,315Daniel Patrick Kelly · University Of Pennsylvania · R01 · FY2021 · HL
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS
$802,177Gerardo Heiss · Univ Of North Carolina Chapel Hill · N01 · FY2021 · HL